Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Zhihui Liu, Ph.D.

Program Director
Division of Cancer Biology (DCB)
DNA and Chromosome Aberrations Research Branch
240-858-3857
|
liuzhihu@mail.nih.gov

Dr. Zhihui Liu manages a portfolio of grants focused on epigenetic and transcriptional dysregulation of cancers. He also has expertise in tumor suppressors and oncogenes. 

Dr. Liu is also interested in cancer cell plasticity and understanding the dynamic role of cellular behavior in malignant transformation and tumor progression.

Background

Before joining DCB, Dr. Liu was a Senior Associate Scientist at NCI investigating mechanisms of tumorigenesis, cancer progression, and therapeutic resistance. He came to DCB to support basic research that he thinks is critical for understanding the fundamental mechanisms of cancer and the development of effective cancer treatments. 

  • Updated:
Email